SNX9 anticorps (AA 85-200)
-
- Antigène Voir toutes SNX9 Anticorps
- SNX9 (Sorting Nexin 9 (SNX9))
-
Épitope
- AA 85-200
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp SNX9 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
- Réactivité croisée
- Humain
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human Sorting nexin-9 protein (85-200AA)
- Isotype
- IgG
- Top Product
- Discover our top product SNX9 Anticorps primaire
-
-
- Indications d'application
- Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200, IF:1:50-1:200,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- SNX9 (Sorting Nexin 9 (SNX9))
- Autre désignation
- SNX9 (SNX9 Produits)
- Synonymes
- anticorps si:bz36d5.4, anticorps snx9, anticorps zgc:113455, anticorps MGC78823, anticorps SNX9, anticorps SDP1, anticorps SH3PX1, anticorps SH3PXD3A, anticorps WISP, anticorps 2700073N08Rik, anticorps sorting nexin 9a, anticorps sorting nexin 9, anticorps sorting nexin 9 L homeolog, anticorps snx9a, anticorps SNX9, anticorps snx9.L, anticorps snx9, anticorps Snx9
- Sujet
-
Background: Involved in endocytosis and intracellular vesicle trafficking, both during interphase and at the end of mitosis. Required for efficient progress through mitosis and cytokinesis. Required for normal formation of the cleavage furrow at the end of mitosis. Plays a role in endocytosis via clathrin-coated pits, but also clathrin-independent, actin-dependent fluid-phase endocytosis. Plays a role in macropinocytosis. Promotes internalization of TNFR. Promotes degradation of EGFR after EGF signaling. Stimulates the GTPase activity of DNM1. Promotes DNM1 oligomerization. Promotes activation of the Arp2/3 complex by WASL, and thereby plays a role in the reorganization of the F-actin cytoskeleton. Binds to membranes enriched in phosphatidylinositol 4,5-bisphosphate and promotes membrane tubulation. Has lower affinity for membranes enriched in phosphatidylinositol 3-phosphate.
Aliases: MST 155 antibody, MST155 antibody, MSTP 155 antibody, MSTP155 antibody, OTTHUMP00000040083 antibody, Protein SDP 1 antibody, Protein SDP1 antibody, SDP 1 antibody, SDP1 antibody, SH3 and PX domain containing protein 3A antibody, SH3 and PX domain containing protein SH3PX1 antibody, SH3 and PX domain-containing protein 1 antibody, SH3 and PX domain-containing protein 3A antibody, SH3PX1 antibody, SH3PXD3A antibody, SNX 9 antibody, SNX9 antibody, SNX9_HUMAN antibody, Sorting nexin 9 antibody, Sorting nexin-9 antibody, WASP interactor protein antibody, Wiskott Aldrich syndrome protein (WASP) interactor protein antibody, Wiskott Aldrich syndrome protein interactor protein antibody, WISP antibody
- UniProt
- Q9Y5X1
-